Highlights
ASX: RAP       RESAPP HEALTH LIMITED
Last Price Today's Change   Day's Range   Trading Volume
0.071   0.00 (0.00%)  0.071 - 0.073  1,030,270

Overview

 
Avg Volume (4 weeks):1,157,644
4 Weeks Range:0.068 - 0.076
4 Weeks Price Volatility (%):
37.50%
52 Weeks Range:0.05 - 0.39
52 Weeks Price Volatility (%):
6.18%
Average Price Target:-

Headlines

Date Subject
10-Jan-2017 ResApp Health extends partnership with Massachusetts General Hospital

Business Background

ResApp Health Limited is engaged in developing digital healthcare solutions to assist doctors and patients to diagnose and manage respiratory disease. The Company offers a range of solutions, such as telehealth, clinical use, direct consumer and big data insights. The Company provides point of care diagnostic solutions for telehealth companies, which is integrated into their platforms. The Company is working on applications to provide clinical quality diagnostic tests and management tools directly to consumers and healthcare providers. The Company is developing smartphone medical applications for the diagnosis and management of respiratory disease. The Company's technology is based on the premise that cough and breathing sounds carry vital information on the state of the respiratory tract. ResApp measures the severity of a range of chronic and acute diseases, such as pneumonia, asthma, bronchiolitis and chronic obstructive pulmonary disease (COPD) using this insight.

  Be the first to like this.
 


 

547  658  687  9248 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 MQA 6.12-0.24 
 PLS 1.025+0.025 
 BPG 0.0080.00 
 TLS 3.69+0.01 
 MDI 0.02-0.002 
 CHP 0.012+0.001 
 AUZ 0.096+0.009 
 VCX 2.83-0.03 
 WFD 9.35-0.14 
 AWC 2.25-0.06 
Partners & Brokers